CME credits: 0.75<br> Valid until: 26-04-2025<br> Claim your CME credit at <a href="https://reachmd.com/programs/cme/managing-immunotherapy-related-adverse-events-during-adjuvant-treatment-for-resectable-melanoma/24382/">https://reachmd.com/programs/cme/managing-immunotherapy-related-adverse-events-during-adjuvant-treatment-for-resectable-melanoma/24382/</a><br> <p>This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropriate agents to improve outcomes for patients with stage IIB-IV resectable melanoma.</p>

ReachMD CME

ReachMD

Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

APR 26, 2024-1 MIN
ReachMD CME

Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

APR 26, 2024-1 MIN

Description

CME credits: 0.75
Valid until: 26-04-2025
Claim your CME credit at https://reachmd.com/programs/cme/managing-immunotherapy-related-adverse-events-during-adjuvant-treatment-for-resectable-melanoma/24382/

This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropriate agents to improve outcomes for patients with stage IIB-IV resectable melanoma.